All Articles

A new study reveals patients trust AI algorithms over doctor recommendations, forcing a high-stakes reckoning for medical practices and patient safety alike.

Litera's Foundation 365 isn't just another CRM. By embedding AI-powered client intelligence into Microsoft 365, it redefines how law firms build relationships.

Crescent's largest-ever fund close highlights booming investor appetite for private credit and promises a major capital infusion for the U.S. lower middle market.

A new AI can detect Parkinson's progression where the current gold standard fails. In a stunning validation, the study was led by the very scientists who created the old method.

Amid global uncertainty, Deerpath Capital's $452M CLO reset offers a masterclass in financial strategy, prioritizing stability for long-term investors.

PBI-Gordon's strategic hire of Kent Luther for Pegasus Labs signals a major push in animal health, blending big pharma talent with an employee-owned model.

With its massive Resulticks acquisition delayed again, London's Diginex tests investor faith, betting its future on an audacious ethics-meets-commerce vision.

The AI boom is hitting a thermal wall. A new solution, born from electric supercar tech, promises to slash energy use and unlock unprecedented power.

Top 20 firm Cherry Bekaert partners with Fieldguide for a massive agentic AI deployment, signaling a major industry shift from point tools to AI-native platforms.

A new free tool promises to arm security providers with an attacker's-eye view, but its real impact may be in reshaping the competitive landscape.

With $50M in pre-sales and a Cabot golf course on the horizon, Revelstoke is redefining mountain living. But can it balance luxury growth with community character?

As autonomous AI enters healthcare, Datavant joins a key consortium to build the safety guardrails, ensuring patient trust and data integrity remain paramount.

For decades, businesses have relied on robust IBM i systems. But what happens when they fail? A new AI-driven approach aims to prevent catastrophe, not just clean it up.

Cemvita's breakthrough 75,000-liter scale-up turns biodiesel waste into renewable oil, paving the way for a new generation of Sustainable Aviation Fuel.

As Prime Medicine prepares for a key investor conference, its next-gen 'search and replace' gene editing technology faces a crucial test. Can it deliver on its promise?

New long-term data for UPLIZNA and TAVNEOS show sustained disease control and reduced steroid use, offering a tangible difference for rare disease patients.

The new INYY ETF promises massive income from Intel's volatility. But a look under the hood reveals NAV erosion, capped gains, and a return of your own capital.

With a major investment from PSG, Dockwa is using AI to transform the $57B marina economy, turning fragmented businesses into a new institutional asset class.

New research reveals high-net-worth investors are abandoning traditional referrals, using AI and digital due diligence to find advisors who truly get them.

MetTel's recent Gartner recognition is more than an accolade; it's a signpost for the future of work where AI and automation manage our corporate devices.